Restoration of BRAK/CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck sauamous cell carcinoma.
Restoration of BRAK/CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck sauamous cell carcinoma.
复制标题
吉非替尼恢复 BRAK/CXCL14 基因表达与该药物在头颈皮肤癌中的抗肿瘤功效相关。
DOI：
--
复制
发表时间：
2009
期刊：
影响因子：
--
通讯作者：
et al.
中科院分区：
文献类型：
--
作者：
Ozawa S;Maehata Y;et al.
